{
    "xml": "<topic id=\"PHP4314\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/carbimazole\" basename=\"carbimazole\" title=\"CARBIMAZOLE\">\n<title>CARBIMAZOLE</title>\n<body>\n<data name=\"vtmid\">325325006</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_892003441\" title=\"Antithyroids\">Antithyroids</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP70193\" outputclass=\"indicationsAndDose\" rev=\"1.34\" parent=\"/drugs/carbimazole\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hyperthyroidism</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8211;40&#8239;mg daily continue until the patient becomes euthyroid, usually after 4 to 8 weeks, higher doses should be prescribed under specialist supervision only, then reduced to 5&#8211;15&#8239;mg daily, reduce dose gradually, therapy usually given for 12 to 18 months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hyperthyroidism (blocking-replacement regimen) in combination with levothyroxine</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8211;60&#8239;mg daily, therapy usually given for 18 months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>When substituting, carbimazole 1&#8239;mg is considered equivalent to propylthiouracil 10&#8239;mg but the dose may need adjusting according to response.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70315\" outputclass=\"importantSafetyInformation\" rev=\"1.8\" parent=\"/drugs/carbimazole\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Neutropenia and agranulocytosis</p>\n<p>Doctors are reminded of the importance of recognising bone marrow suppression induced by carbimazole and the need to stop treatment promptly.</p>\n<ol>\n<li>Patient should be asked to report symptoms and signs suggestive of infection, especially sore throat.</li>\n<li>A white blood cell count should be performed if there is any clinical evidence of infection.</li>\n<li>Carbimazole should be stopped promptly if there is clinical or laboratory evidence of neutropenia.</li>\n</ol>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70354\" outputclass=\"contraindications\" rev=\"1.8\" parent=\"/drugs/carbimazole\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Severe blood disorders</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70092\" outputclass=\"sideEffects\" rev=\"1.23\" parent=\"/drugs/carbimazole\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">mild gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">taste disturbance</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Agranulocytosis</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">bone marrow suppression</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">myopathy</ph>; <ph outputclass=\"sideEffect\">pancytopenia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p>Rashes and pruritus are common with carbimazole but they can be treated with antihistamines without discontinuing therapy; alternatively propylthiouracil can be substituted.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70146\" outputclass=\"pregnancy\" parent=\"/drugs/carbimazole\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Carbimazole can be given but the blocking-replacement regimen is <b>not</b> suitable. Rarely, carbimazole has been associated with congenital defects, including aplasia cutis of the neonate.Carbimazole cross the placenta and in high doses may cause fetal goitre and hypothyroidism&#8212;the lowest dose that will control the hyperthyroid state should be used (requirements in Graves&#8217; disease tend to fall during pregnancy).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70441\" outputclass=\"breastFeeding\" parent=\"/drugs/carbimazole\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in breast milk but this does not preclude breast-feeding as long as neonatal development is closely monitored and the lowest effective dose is used. Amount in milk may be sufficient to affect neonatal thyroid function therefore lowest effective dose should be used.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70237\" outputclass=\"hepaticImpairment\" parent=\"/drugs/carbimazole\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in mild to moderate impairment.</p>\n<p>Avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70136\" outputclass=\"patientAndCarerAdvice\" rev=\"1.11\" parent=\"/drugs/carbimazole\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Warn patient or carers to tell doctor <b>immediately</b> if sore throat, mouth ulcers, bruising, fever, malaise, or non-specific illness develops.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4314-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/carbimazole\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension, capsule</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75867\" title=\"Tablet\" namespace=\"/drugs/carbimazole/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97237\" namespace=\"/guidance/adverse-reactions-to-drugs\" title=\"Adverse reactions to drugs\" count=\"1\" rel=\"backlink\">Adverse reactions to drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78280\" namespace=\"/treatment-summaries/antithyroid-drugs\" title=\"Antithyroid drugs\" count=\"6\" rel=\"backlink\">Antithyroid drugs</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75867\" namespace=\"/drugs/carbimazole/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP4314",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/carbimazole",
    "basename": "carbimazole",
    "title": "CARBIMAZOLE",
    "vtmid": "325325006",
    "drugClassification": [
        "Antithyroids"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Hyperthyroidism",
                        "html": "Hyperthyroidism"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "15&#8211;40 mg daily continue until the patient becomes euthyroid, usually after 4 to 8 weeks, higher doses should be prescribed under specialist supervision only, then reduced to 5&#8211;15 mg daily, reduce dose gradually, therapy usually given for 12 to 18 months.",
                        "html": "<p>15&#8211;40&#8239;mg daily continue until the patient becomes euthyroid, usually after 4 to 8 weeks, higher doses should be prescribed under specialist supervision only, then reduced to 5&#8211;15&#8239;mg daily, reduce dose gradually, therapy usually given for 12 to 18 months.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hyperthyroidism (blocking-replacement regimen) in combination with levothyroxine",
                        "html": "Hyperthyroidism (blocking-replacement regimen) in combination with levothyroxine"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "40&#8211;60 mg daily, therapy usually given for 18 months.",
                        "html": "<p>40&#8211;60&#8239;mg daily, therapy usually given for 18 months.</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "When substituting, carbimazole 1 mg is considered equivalent to propylthiouracil 10 mg but the dose may need adjusting according to response.",
                "html": "<p>When substituting, carbimazole 1&#8239;mg is considered equivalent to propylthiouracil 10&#8239;mg but the dose may need adjusting according to response.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "Neutropenia and agranulocytosis",
                "textContent": "Doctors are reminded of the importance of recognising bone marrow suppression induced by carbimazole and the need to stop treatment promptly.\n\nPatient should be asked to report symptoms and signs suggestive of infection, especially sore throat. A white blood cell count should be performed if there is any clinical evidence of infection. Carbimazole should be stopped promptly if there is clinical or laboratory evidence of neutropenia.",
                "html": "<p>Doctors are reminded of the importance of recognising bone marrow suppression induced by carbimazole and the need to stop treatment promptly.</p><ol>\n<li>Patient should be asked to report symptoms and signs suggestive of infection, especially sore throat.</li>\n<li>A white blood cell count should be performed if there is any clinical evidence of infection.</li>\n<li>Carbimazole should be stopped promptly if there is clinical or laboratory evidence of neutropenia.</li>\n</ol>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Severe blood disorders",
                "html": "Severe blood disorders"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "malaise",
                        "html": "malaise",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "mild gastro-intestinal disturbances",
                        "html": "mild gastro-intestinal disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "taste disturbance",
                        "html": "taste disturbance",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Agranulocytosis",
                        "html": "Agranulocytosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "bone marrow suppression",
                        "html": "bone marrow suppression",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "myopathy",
                        "html": "myopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "pancytopenia",
                        "html": "pancytopenia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "textContent": "Rashes and pruritus are common with carbimazole but they can be treated with antihistamines without discontinuing therapy; alternatively propylthiouracil can be substituted.",
                "html": "<p>Rashes and pruritus are common with carbimazole but they can be treated with antihistamines without discontinuing therapy; alternatively propylthiouracil can be substituted.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Carbimazole can be given but the blocking-replacement regimen is not suitable. Rarely, carbimazole has been associated with congenital defects, including aplasia cutis of the neonate.Carbimazole cross the placenta and in high doses may cause fetal goitre and hypothyroidism&#8212;the lowest dose that will control the hyperthyroid state should be used (requirements in Graves&#8217; disease tend to fall during pregnancy).",
                "html": "<p>Carbimazole can be given but the blocking-replacement regimen is <b>not</b> suitable. Rarely, carbimazole has been associated with congenital defects, including aplasia cutis of the neonate.Carbimazole cross the placenta and in high doses may cause fetal goitre and hypothyroidism&#8212;the lowest dose that will control the hyperthyroid state should be used (requirements in Graves&#8217; disease tend to fall during pregnancy).</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in breast milk but this does not preclude breast-feeding as long as neonatal development is closely monitored and the lowest effective dose is used. Amount in milk may be sufficient to affect neonatal thyroid function therefore lowest effective dose should be used.",
                "html": "<p>Present in breast milk but this does not preclude breast-feeding as long as neonatal development is closely monitored and the lowest effective dose is used. Amount in milk may be sufficient to affect neonatal thyroid function therefore lowest effective dose should be used.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in mild to moderate impairment.\n\nAvoid in severe impairment.",
                "html": "<p>Use with caution in mild to moderate impairment.</p><p>Avoid in severe impairment.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Warn patient or carers to tell doctor immediately if sore throat, mouth ulcers, bruising, fever, malaise, or non-specific illness develops.",
                "html": "<p>Warn patient or carers to tell doctor <b>immediately</b> if sore throat, mouth ulcers, bruising, fever, malaise, or non-specific illness develops.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension",
                "capsule"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75867",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP97237",
                "label": "Adverse reactions to drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78280",
                "label": "Antithyroid drugs",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75867",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}